Page results
- 
                                    
                                                                            This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen 
- 
                                    
                                                                            Information on safer eating during treatment, for patients with blood cancer. 
- 
                                    
                                                                            This page explains what extravasation is, and outlines the steps we take when it occurs. 
- 
                                    
                                                                            Information about the use of deferasirox iron chelation treatment for iron overload. 
- 
                                    
                                                                            Information about community sickle cell and thalassaemia services provided via UCLH. 
- 
                                    
                                                                            This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia. 
- 
                                    
                                                                            The UCLH Lymphoma multidisciplinary team (MDT) provides specialist care for people with lymphoma. 
File results
- 
                                                                            FOI/2023/0331 - Sexual assaults in hospitals from 2020 to 2023 
- 
                                                                            FOI/2023/0292 - Spend on bank/ agency/ locum staff for junior doctor strike cover 
- 
                                                                            FOI/2023/0299 - Trust Medical Examiner contact details 
- 
                                                                            FOI/2023/0303 - Sexual harassment from patients towards staff in 2022 
- 
                                                                            FOI/2023/0305 - Trust held non-pharmaceutical consignment stock holding 
- 
                                                                            FOI/2023/0308 - Treatment for biologic and biosimilar products within rheumatology 
- 
                                                                            FOI/2023/0310 - Biologic treatment/ medicines in dermatology 
- 
                                                                            FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine 
- 
                                                                            FOI/2023/0338 - Individuals with a change to a gene called CACNA1C for 2021 and 2022 
- 
                                                                            FOI/2023/0340 - NHS charging of overseas visitors